Keystone Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2003



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

B Cells and Antibodies: Laboratory to Clinic (A5)


Organizer(s) Michel C. Nussenzweig, Frederick W. Alt and Louis M. Staudt
January 14—19, 2003
Keystone Resort • Keystone, Colorado USA
Abstract Deadline: Sep 16, 2002
Late Abstract Deadline:
Scholarship Deadline:
Early Registration Deadline: Nov 14, 2002

Sponsored in part by The Director's Sponsor Fund

Summary of Meeting:
B lymphocytes produce antibodies which are important mediators of humoral immune responses. Key advances have been made in understanding the generation of the diverse antibodies required to ?see? the antigenic world. Mechanistic insights have been gained in the areas of V(D)J recombination and it?s regulation during B cell development. In addition there has been a great deal of progress in the understanding of somatic hypermutation and switch recombination, two other somatic DNA modification reactions that contribute to antibody gene diversification. Antigen receptor assembly in developing B cells triggers a group of signaling pathways that are being defined, and many of the same pathways appear to regulate induction of tolerance and B cell responses to antigen in the periphery. New approaches to the mechanisms that establish B cell tolerance are being exploited to understand the balance between immunity and autoimmunity. Progress has also been made in using antibodies in therapeutic approaches in a number

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


TUESDAY, JANUARY 14

15:00—19:00
Registration

Shavano Peak Foyer
18:15—19:15
Welcome

Shavano Peak Foyer
19:15—19:30
Orientation

Crestone/Red Cloud
19:30—20:30
Keynote Address
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
Tasuku Honjo, Kyoto University Graduate School of Medicine, Japan
AID Links Class Switching and Somatic Hypermutation


WEDNESDAY, JANUARY 15

07:00—08:00
Breakfast

Grays
08:00—11:00
Early B Cell Development
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Cornelis Murre, University of California, San Diego, USA
Regulation and Function of Helix-Loop-Helix Proteins in Lymphocyte Development

Christopher J. Paige, Ontario Cancer Institute, Canada
B Cell Development: The Role of IL-7, preBcR and HK-1

Meinrad Busslinger, Research Institute of Molecular Pathology, Austria
The Role of Pax5 in Early B Cell Development

Mark S. Schlissel, University of California, Berkeley, USA
Transcriptional Regulation in V(D)J Recombination

Yehudit Bergman, Hebrew University Medical School, Israel
Allelic Exclusion in the Immune System

Amanda G. Fisher, MRC Clinical Sciences Centre, Imperial College London, UK
Short Talk: Using B Cells to Deliver Therapeutic Proteins

Harinder Singh, Cincinnati Children's Hospital Medical Center, USA
Short Talk: Control of B Cell Development by PU.1 and the Interacting Transcription Factors Pip (IRF-4) and ICSBP (IRF-8)

09:20—09:40
Coffee Break

Shavano Peak Foyer
11:00—13:00
Poster Setup

Shavano/Torreys
13:00—22:00
Poster Viewing

Shavano/Torreys
14:30—16:30
Workshop 1: B Cell Development

Crestone Peak
* Fritz Melchers, Biozentrum of the University of Basel, Switzerland

* Marjorie A. Oettinger, Massachusetts General Hospital, USA

Leo D. Wang, Beckman Research Institute, City of Hope, USA
Examination of the Role of Ig-alpha and Ig-beta in B Cell Development

Sandra Thiemann, University of California, Los Angeles, USA
The Role of Ig-alpha in the Context of B Cell Development and Function

Yoshiyuki Minegishi, University of Tokushima, Japan
In vivo Functional Characterization of Light Chain-Independent mu Heavy Chain

Inga-Lill Mårtensson, Babraham Institute, UK
Does the Absence of Ig-kappa Light Chain Alter Early B Cell Development in Surrogate Light Chain Deficient Mice?

Mila Jankovic, Rockefeller University, USA
OcaB Regulates Transitional B Cell Selection

Anne E. Corcoran, Babraham Institute, UK
The Pre-BCR Signals Expansion in the Absence of the Interleukin-7 Receptor

A. Byron Cooper, University of Chicago, USA
A Role for the Extracellular Domain of Ig-beta in B Cell Receptor Assembly, Signaling and Development

Shirly Becker-Herman, University of Washington, USA
The Lumenal Domain of Invariant Chain Controls NF-kappaB Activation and B Cell Maturation

14:30—16:30
Workshop 2: BCR Signaling

Red Cloud Peak
* John C. Cambier, University of Colorado, USA

* Selina Chen-Kiang, Weill Medical College of Cornell University, USA

Lina E. Tze, John Curtin School of Medical Research, Australian National University, Australia
Basal Immunoglobulin Signaling Maintains Allelic Exclusion and Developmental Stage in Immature B Cells

Hassan Jumaa, Institute for Immunology, Ulm University Hospital, Germany
LAT Links the Pre-BCR to Calcium Signaling

Kaoru Saijo, University of California, Berkeley, USA
Src-Family Kinase, Blk, Fyn and Lyn are Essential for B Cell Development by Regulating NF-kappaB Activation

Sabine Middendorp, Erasmus MC, Netherlands
Differential Role of Bruton’s Tyrosine Kinase (Btk)-Domains in Pre-B Cell Receptor Checkpoint Function

Stephen B. Gauld, Children's Research Institute, Medical College of Wisconsin, USA
Reversibility of B Cell Anergy in the Ars/A1 Transgenic Mouse Model

Marina Kremyanskaya, University of Pennsylvania, USA
The BCR Components Physically Uncouple Following Antigen Binding

Arnold Han, Rockefeller University, USA
Functional Analysis of the Bam32 Signaling Adaptor

Joseph M. Dal Porto, Pfizer Center for Therapeutic Innovation, USA
Regulation of BCR Signal Transduction in CD5+ B-1 Cells Requires the T Cell-Associated Src-Family Kinase, Lck

16:30—17:00
Coffee & Snacks Available

Shavano Peak Foyer
17:00—19:00
Mechanisms of B Cell Activation
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Alexander Tarakhovsky, Rockefeller University, USA

Tomohiro Kurosaki, WPI Immunology Frontier Research Center, Osaka University, Japan
Regulation of B Cell Activation by Adaptor Molecules

Michael C. Carroll, Boston Children's Hospital, Harvard Medical School, USA
The Role of Complement in Adaptive Immune Responses

Michael Reth, Albert-Ludwigs University Freiburg, Germany
Positive and Double-Negative Feedback Loops in the Initiation of BCR Signaling

Jeffrey V. Ravetch, Rockefeller University, USA
Modulating Autoimmunity through Fc Receptors

Edward A. Clark, University of Washington, USA
Short Talk: B Cell Receptor Internalization and JNK Activation are Regulated by the Adaptor Bam32

John C. Cambier, University of Colorado, USA
Short Talk: Molecular Circuitry Preventing Activation of Anergic B Cells

19:00—20:00
Social Hour

Shavano/Torreys
20:00—22:00
Poster Session 1: B Cell Development/BCR Signaling

Shavano/Torreys

THURSDAY, JANUARY 16

07:00—08:00
Breakfast

Grays
08:00—11:00
Clinical B Cell Immunology I
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Louis M. Staudt, NCI, National Institutes of Health, USA
Molecular Diagnosis of Human Lymphoid Malignancies

Ralf Küppers, University of Duisburg-Essen, Medical School, Germany
Aspects of Somatic Hypermutation, Epstein-Barr Virus Biology and B Cell Lymphomagenesis in the Human

Riccardo Dalla-Favera, Columbia University, USA
Molecular Pathogenesis of B Cell Non-Hodgkin Lymphoma

Luigi D. Notarangelo, Children's Hospital, Boston, USA
Molecular and Cellular Analysis of CD40 Deficiency

Mary Ellen Conley, Rockefeller University, USA
Short Talk: Defects in B Cell Development

09:20—09:40
Coffee Break

Shavano Peak Foyer
11:00—13:00
Poster Setup

Shavano/Torreys
13:00—22:00
Poster Viewing

Shavano/Torreys
14:30—16:30
Workshop 3: Autoimmunity

Crestone Peak
* Mark J. Shlomchik, University of Pittsburgh School of Medicine, USA

* Ann Marshak-Rothstein, University of Massachusetts Medical School, USA

Nili Feuerstein, University of Pennsylvania, USA
Failure of Ig Light Chain Receptor Editing in Immature Bone Marrow Self Reactive B Cells in Chronic GVH

Ingrid Mecklenbräuker, Rockefeller University, USA
Protein Kinase Cdelta Controls Self-Antigen Induced B Cell Tolerance

Nancy L. Monson, University of Texas Southwestern Medical Center, USA
Clonal Expansion of CSF B Cells is Limited in Patients with Early Multiple Sclerosis

Ignacio Sanz, Emory University, School of Medicine, USA
A Population of Human Autoreactive B-Cells Cells is Excluded from the Germinal Centers in Healthy Subjects but not in SLE

Nancy S. Longo, NIAID, National Institutes of Health, USA
Abnormal Selection and B Cell Memory in ALPS

Maria J. Leandro, University College London, UK
An Open Study of B Lymphocyte Depletion in Systemic Lupus Erythematosus

Eric Meffre, Yale University School of Medicine, USA
Human B Cells that Express Surrogate Light Chains Produce Self-Reactive Antibodies

14:30—16:30
Workshop 4: Late B Cell Differentiation

Red Cloud Peak
* Kathryn L. Calame, Columbia College of Physicians and Surgeons, USA

Raul M. Torres, University of Colorado School of Medicine, USA
B Cell Interactions in T-Dependent Antibody Responses

Manfred Kraus, Harvard Medical School, USA
Conditional Ablation of BCR Signaling Capacity via Cre-loxP Mediated Mutation of Igalpha

Ramit Mehr, Bar-Ilan University, Israel
The Dynamics of Germinal Center Selection as Measured by Graph-Theoretical Analysis of Mutational Lineage Trees

Amrie C. Grammer, AMPEL BioSolutions LLC, USA
Engagement of CD154 Expressed by Human Tonsillar B Cells Induces Proximal Signaling Events and Differentiation to Ig-Secreting PCs

Miriam A. Shapiro, Columbia University, USA
Defective Plasma Cell Function in Mice Lacking Blimp-1 in B Cells

Shane Crotty, La Jolla Institute for Allergy and Immunology, USA
SAP is Required for the Generation of Long Term Humoral Immunity

Carla Blanco-Betancourt, Centre d'Immunologie de Marseille-Luminy, France
Defective Terminal B Cell Differentiation Results in Agammaglobulinemia in ICF Syndrome

Sidonia Fagarasan, RIKEN Research Center for Allergy and Immunology, Japan
Critical Roles of Intestinal Isolated Lymphoid Follicles in Homeostasis of the Gut Flora

16:30—17:00
Coffee & Snacks Available

Shavano Peak Foyer
17:00—19:00
Autoimmunity
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
Martin G. Weigert, University of Chicago, USA
Receptor Editing and Autoimmunity

David Nemazee, The Scripps Research Institute, USA
RNA Analysis of Receptor Editing

Christopher C. Goodnow, Garvan Institute of Medical Research, Australia
Tolerogenic versus Immunogenic Signaling

* Diane Mathis, Harvard Medical School, USA
An Immunoglobulinocentric View of Inflammatory Arthritis

Ann Marshak-Rothstein, University of Massachusetts Medical School, USA
Short Talk: B Cell Receptor/Toll-Like Receptor Synergy in Systemic Autoimmune Disease

Mark J. Shlomchik, University of Pittsburgh School of Medicine, USA
Short Talk: Activation and Regulation of Rheumatoid Factor B Cells in vivo

19:00—20:00
Social Hour

Shavano/Torreys
20:00—22:00
Poster Session 2: Autoimmunity/Late B Cell Differentiation/ B Cell Malignancies/B Cell Deficiencies

Shavano/Torreys

FRIDAY, JANUARY 17

07:00—08:00
Breakfast

Grays
08:00—11:00
Antigen Receptor Diversification I: V(D)J Recombination, Somatic Mutation, Switch Recombination and DNA Repair
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Frederick W. Alt, Boston Children's Hospital, USA
Role of DNA Repair Factors in V(D)J Recombination and Class Switching

Jean-Pierre de Villartay, INSERM U768, France
Role of Artemis in V(D)J Recombination and DNA Repair

David G. Schatz, Yale University School of Medicine, USA
Regulating the V(D)J Recombination Machine

Martin Gellert, NIDDK, National Institutes of Health, USA
Multiple Roles of the Rag Proteins in Recombination and Transposition

Michael S. Krangel, Duke University Medical Center, USA
Accessibility Control of V(D)J Recombination: Lessons from TCR Loci

Marjorie A. Oettinger, Massachusetts General Hospital, USA
Short Talk: Chromatin Modifications Defining the Long-Range Organization and Boundaries of Antigen Receptor Loci

09:20—09:40
Coffee Break

Shavano Peak Foyer
11:00—13:00
Poster Setup

Shavano/Torreys
13:00—22:00
Poster Viewing

Shavano/Torreys
14:30—16:30
Workshop 5: Antigen Receptor Diversification 2, Somatic Hypermutation and Switch Recombination

Crestone Peak
* Ursula Storb, University of Chicago, USA

* Janet M. Stavnezer, University of Massachusetts Medical School, USA

Caroline J. Woo, Massachusetts General Hospital, USA
V Region Chromatin Modifications are Associated with the Induction of Mutation in BL2 Cells

Patricia J. Gearhart, NIA, National Institutes of Health, USA
DNA Polymerase Iota-Deficient Mice Have Hypermutation of Ig Variable Genes

F. Nina Papavasiliou, Rockefeller University, USA
AID Functions as a DNA Deaminase in vitro

Simonne Longerich, University of Chicago, USA
Targeted Double-Strand Breaks in a Constitutively Hypermutating B Cell Line

Carol E. Schrader, University of Massachusetts, USA
Ercc1 Deficient B Cells show Reduced Class Switch Recombination and Altered Switch Recombination Junctions

Michael R. Ehrenstein, University College London, UK
Impaired DNA Ligase IV Activity in a Patient Results in Microhomology at Ig Switch Recombination Junctions

Amy L. Kenter, University of Illinois College of Medicine, USA
Functional Recombination Motifs are Defined for m->g3 Class Switch Using AID Dependent Extrachromosomal Switch Substrates

14:30—16:30
Workshop 6: B Cell Co-Receptors

Red Cloud
* Edward A. Clark, University of Washington, USA

Lars Nitschke, University of Erlangen, Germany
Sialic-Acid Binding of CD22 is Required for Inhibition of the BCR Signal

Yue Wang, University of Alabama at Birmingham, USA
CD19 Y482 and Y513 Regulate Cell Cycling and Thereby Maturation, Class Switching and Antibody Responses in Germinal Center B Cells

Amy N. Anzelon Mills, Sanford-Burnham Medical Research Institute, USA
Pten Inactivation Leads to Altered B Cell Fate and Reconstitutes CD19 Function

Robert A. Barrington, Center for Blood Research, USA
Regulated Survival of Activated B Lymphocytes by Complement Receptors CD21/CD35

Chie Watanabe, University of Washington, USA
Regulation of BCR and FcgammaRIIB Signals by a Lymphocyte Semaphorin, CD100

Katia Basso, Columbia University, USA
Tracking CD40 Signaling in Normal B Cells by Gene Expression Profiling

Stuart G. Tangye, Garvan Institute of Medical Research, Australia
Complementary Roles of CD40L and BAFF in the Differentiation of Human Memory B Cells

Susan M. Harless, University of Pennsylvania, USA
Activated B Lymphocytes Remain Responsive to BLyS-Mediated Survival Signals by Upregulating Bcmd/BR3 Expression

14:30—16:30
Workshop 7: Transcriptional Regulation in Recombination and Development

Quandary 1
* Amanda G. Fisher, MRC Clinical Sciences Centre, Imperial College London, UK

* Harinder Singh, Cincinnati Children's Hospital Medical Center, USA

Holly Maier, National Jewish Medical and Research Center, USA
Activation of the Early B Cell-Specific mb-1(Ig-alpha) Gene by Pax-5 is Dependent on an Unmethylated Ets Binding Site

Runqing Lu, University of Nebraska Medical Center, USA
Essential Role of IRF4/Pip and IRF8/ICSBP in B Cell Development

Zhixin Zhang, University of Nebraska Medical Center, USA
BSAP Transactivates RAG-Mediated Immunoglobulin Gene Recombination

Lih-Yun Hsu, University of California, Berkeley, USA
Role of Pax5/BSAP in B Cell Fate Specification

David G.T. Hesslein, University of California, San Francisco, USA
Pax5-Dependent Control of the IgH Locus during Early B Cell Development

Victoria E. Wang, Massachusetts Institute of Technology, USA
Characterization of the Role of OCT-1 during Embryonic Development and Lymphopoiesis

Timothy P. Bender, University of Virginia Health System, USA
Roles for c-myb at Multiple Stages during B-Lymphopoiesis

Matthew A. Inlay, University of California, San Diego, USA
Functional Analysis of the Immunoglobulin kappa Enhancers

Barbara K. Birshtein, Albert Einstein College Of Medicine, USA
The Extent of B Cell-Specific Regulation of the Igh Gene Cluster

16:30—17:00
Coffee & Snacks Available

Shavano Peak Foyer
17:00—19:00
Late B Cell Differentiation
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Ian C.M. MacLennan, University of Birmingham, UK
Extrafollicular Antibody Responses

Michael G. McHeyzer-Williams, The Scripps Research Institute, USA
Organization and Developmental Progression in Antigen-Specific B Cell Memory

Jason G. Cyster, HHMI/University of California, San Francisco, USA
B Cell Trafficking in Immune Tissues

Laurie H. Glimcher, Dana-Farber Cancer Institute, USA
Plasma Cell Differentiation and the Unfolded Protein Response Intersect at the Transcription Factor XBP-1

Kathryn L. Calame, Columbia College of Physicians and Surgeons, USA
Short Talk: A Requirement for Blimp-1 in Differentiation of Ig-Secreting Cells

Selina Chen-Kiang, Weill Medical College of Cornell University, USA
Short Talk

19:00—20:00
Social Hour

Shavano/Torreys
20:00—22:00
Poster Session 3: V(D)J Recombination/Somatic Mutation/Switch Recombination/Transcriptional Regulation

Shavano/Torreys

SATURDAY, JANUARY 18

07:00—08:00
Breakfast

Grays
08:00—11:00
Antigen Receptor Diversification II: V(D)J Recombination, Somatic Mutation, Switch Recombination and DNA Repair
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Michel C. Nussenzweig, HHMI/Rockefeller University, USA

Michael S. Neuberger, Medical Research Council, UK
Antibody Diversification by AID-Triggered DNA Deamination

Claude-Agnès Reynaud, Necker-Paris Medical School, France
Beyond AID: Study of Hypermutation in Burkitt's Lymphomas

Stefano Casola, Center for Blood Research, Harvard Medical School, USA
Monitoring the Dependence of B Cell Differentiation on BCR Signal Strength via a BCR Surrogate, the Epstein-Barr-Virus-Derived LMP2A

Alberto Martin, University of Toronto, Canada
Short Talk: Mismatch Repair in Antibody Diversification.

Ursula Storb, University of Chicago, USA
Short Talk

Janet M. Stavnezer, University of Massachusetts Medical School, USA
Short Talk

09:20—09:40
Coffee Break

Shavano Peak Foyer
14:30—16:30
Workshop 8: Human B Cell Malignancies

Crestone
* Thomas J. Kipps, University of California, San Diego, USA

* Nicholas Chiorazzi, Feinstein Institute for Medical Research, USA

Jobst C. Greeve, Inselspital University-Hospital Bern, Switzerland
Expression of Activation-Induced Cytidine Deaminase in Human B-Cell Non-Hodgkin Lymphomas

Bradley T. Messmer, Abreos Biosciences, USA
Activation-Induced Cytidine Deaminase (AID) Expression in B-CLL

Laura Pasqualucci, Columbia University, USA
Transcriptional Deregulation of Mutated BCL6 Alleles by Loss of Negative Autoregulation in Diffuse Large B-Cell Lymphoma

Xing Wang, Albert Einstein College of Medicine, USA
A Negative Auto-Regulation Mechanism that Controls BCL6 Transcription is Bypassed in DLCL Cells Carrying Activating BCL6 Mutations

Andre Limnander, Regeneron, USA
v-Abl Induced Jak-Stat Activation is Resistant to Socs1 Inhibition

Davorka Messmer, Inception Sciences, USA
Direct Measurement of B-CLL Cell Production and Turnover in vivo

Juan F. Garcia, Spanish National Cancer Center, Spain
cDNA Microarray Analyses in Mantle Cell Lymphomas

14:30—16:30
Workshop 9: Antigen Receptor Diversification 1, (V(D)J Recombination

Red Cloud Peak
* Max D. Cooper, Emory University, USA

* Mary Ellen Conley, Rockefeller University, USA

I-hsin Su, Rockefeller University, USA
Novel Mechanism of the Regulation of Immunoglobulin Heavy Chain Gene Rearrangement by the Polycomb Group Protein Enx-1

Kristy Johnson, Pfizer, Inc., USA
Beginning to Unravel the Histone Code of the VH Locus

Yoshiko Akamatsu, Abbvie Inc., USA
Differential Effects of CpG Methylation at the Recombination Signal Sequences on the Reactivity of RAG1/2 Complex

Fumikiyo Nagawa, University of Tokyo, Japan
Footprint Analysis of Recombination Signal Sequences in the 12/23 Synaptic Complex of V(D)J Recombination

Katheryn D. Meek, Michigan State University, USA
Poly-Autophosphorylation of DNA-PK on a Small Cluster of Sites within the Catalytic Subunit, is Requisite to its Role in Non-Homologous End Joining

Jane A. Skok, New York University School of Medicine, USA
Nuclear Organization of Immunoglobulin Genes

Harry W. Schroeder, University of Alabama, Birmingham, USA
Impeded B Cell Development, Impaired Immune Response and Increased Frequency of IgG Anti-ds DNA Autoantibodies in a Mouse with an Altered DH Locus

Maria M. Souto-Carneiro, NIAMS, National Institutes of Health, USA
V(D)J Recombination Abnormalities in Patients with X-Linked Hyper-IgM Ectodermal Dysplasia Syndrome

16:30—17:00
Coffee & Snacks Available

Shavano Peak Foyer
17:00—19:00
Clinical B Cell Immunology II
Meeting has ended...abstracts no longer viewable online.

Crestone/Red Cloud
* Stanley J. Korsmeyer, Harvard University, USA
Apoptosis Targeting in Lymphoma

Craig B. Thompson, Memorial Sloan Kettering Cancer Center, USA
Antiapoptotic Genes Involved in the Pathogenesis of Lymphoma: Bcl-2 is not Enough

Tak W. Mak, Campbell Family Institute for Breast Cancer, Canada
Molecular Pathogenesis of B Cell Lymphoma

Anne Durandy, Institut Imagine, France
Inherited Models of Class Switch Recombination and Somatic Hypermutation Generation Defects

19:00—20:00
Social Hour

Shavano/Torreys
20:00—23:00
Entertainment

Shavano/Torreys

SUNDAY, JANUARY 19

 
Departure


*Session Chair †Invited, not yet responded.



We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676